Prelude Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $226K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $216K | Sell |
|
|||||
|
2024
Q2 | $362K | Buy |
|
|||||
|
2024
Q1 | $306K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $1.95M | Buy |
|
|||||
|
2023
Q2 | $1.29M | Buy |
|
|||||
|
2023
Q1 | $249K | Sell |
|
|||||
|
2022
Q4 | $259K | Sell |
|
|||||
|
2022
Q3 | $597K | Buy |
|
|||||
|
2022
Q2 | $513K | Sell |
|
|||||
|
2022
Q1 | $2.36M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1.18M | Buy |
|
|||||
|
2021
Q2 | $686K | Buy |
|
|||||
|
2021
Q1 | – | Hold |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $211K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $89K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $964K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $494K | Sell |
|
|||||
|
2016
Q2 | $491K | Buy |
|
|||||
|
2016
Q1 | $434K | Sell |
|
|||||
|
2015
Q4 | $815K | Buy |
|
|||||
|
2015
Q3 | $314K | Sell |
|
|||||
|
2015
Q2 | $962K | Buy |
|
|||||
|
2015
Q1 | $807K | Buy |
|
|||||
|
2014
Q4 | $665K | Buy |
|
|||||
|
2014
Q3 | $471K | Hold |
|
|||||
|
2014
Q2 | $457K | Buy |
|
|||||
|
2014
Q1 | $309K | Buy |
|
|||||
|
2013
Q4 | $78K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $51K | Buy |
|